Bilcare Share Price

    BSE
    71.5
    -1.67 (2.78%)
    BI • 04 Jul, 2025 | 03:30 PM
    BUY

    1Y Annualised Return

    24.86%

    3Y Annualised Return

    4.38%

    5Y Annualised Return

    4.62%

    The current prices are delayed, login or Open Demat Account for live prices.

    Bilcare Stock Performance

    1W Return-5.99
    1Y Return22.05
    Today's Low71.32
    Prev. Close73.17
    Mkt Cap (Cr.)168.40
    1M Return-10.36
    3Y Return10.88
    52-Week High97.99
    Open73.16
    PE Ratio42.32
    6M Return-11.65
    Today's High74.39
    52-Week Low51
    Face Value10

    Bilcare Company background

    Founded in: 1987
    Managing director: Shreyans Bhandari
    Bilcare Ltd was incorporated in July, 1987 as Bhandari Paper Products Pvt Ltd and converted into a public limited company on October 27, 1994. The name of the company was changed to BI Ltd in the year 2001 and further the name was changed to Bilcare Ltd on October 1, 2003. The Company is a researchbased organization primarily engaged in manufacturing specialty pharmaceutical packaging barrier films. It provides pharmaceutical research services, clinical services and packaging systems and material. The companys key products include packaging films, aluminum foils, wrap systems, cold formed blisters, closures and containers, and paper composites. They also offer research services, including preformulation studies, formulation development, analytical research, stability studies, packaging audit and packaging development and design. The companys plant at Rajgurunagar in Pune is one of its kinds in Asia and the eighth plant of its kind in the world. During the year 199798, company completed the project of Paper Tube Plant at Patalganga in Maharashtra. During the year 19992000, German Investment and Development company namely DEG Deutsche Investitions Und Entwicklungsgesellschaft MBH has subscribed to 21% of the share capital of PT Bhandari Mishindo, a subsidiary of the company. During the year 200203, the company introduced seven new unique products for the pharma sector namely Nova, Patina, Ultra, Excel, Super Zing and Venus.During the year 200304, the company hived off their Biltube Division in order to focus their core business of manufacture of pharma packaging and research. Also, PT Bhandari Mishindo, a subsidiary company in Indonesia which was formed as an integral part of the Biltube Division was ceased to be a subsidiary of the company. Also, the company promoted Bilcare Singapore Pte Ltd as a wholly owned subsidiary of the company during the year.In July 2005, Bilcare Singapore Pte Ltd, a wholly owned subsidiary of the company acquired pharma research and clinical services business in USA. Thus Bilcare Inc became a subsidiary of the company. In October 2005, the company unveiled their clinical services facility in Pune. This facility will support the pharma companies in packaging and distribution of their clinical supplies and integrate their global clinical trial requirements efficiently.In September 2006, the company acquired DHP Ltd, a UKbased Clinical Trials Services provider through Bilcare (UK) Ltd, a wholly owned subsidiary of Bilcare Singapore Pte Ltd. In May 2007, Bilcare Research announced the launch of the Bilcare Research Academy in partnership with Association of Clinical Research Professionals (ACRP), US. The academy shall open 25 centers in India and other parts of Asia by 2010.In January 2008, Bilcare Singapore has bought 100% of Singular ID, the provider of integrated high technology enterprise brand security system, for a consideration of Singapore Dollar 19.58 million. Bilcare Singapore is a wholly owned subsidiary of the company. In July 2008, Bilcare Ltd and USA based MeadWestvaco Corp jointly acquired the pharmaceutical packaging Company International Labs of St. Petersburg, Florida, USA.In FY 2013 14, the Company started commercial production of the specialty cold formable blister (CFB) film on the newly commissioned state of the art multilayer laminator. The RD team successfully developed Bilcare Armour for packaging of highly moisture sensitive formulations in a cost effective manner by replacing conventional high cost material used for packaging of highly moisture sensitive pharmaceutical formulations. Another key RD activity was the successful development and commercialization of specialty triplex and duplex film laminates comprising PVC/EVOH/Aclar for Oxygen sensitive formulations as well as PVC/PE/Aclar, CPP/Aclar (Polyolefin base) and APET/ Aclar (polyester base) for pharmaceutical applications as green (halogenfree) packaging alternatives. A novel Surlyn based composite film laminate was developed for formulations required to be packaged at low temperatures.In 2023, the Company transferred its Pharma Packaging Division (PPI) Division as a business undertaking on a going concern basis to its subsidiary, Caprihans India Limited through slump sale, for a net consideration of Rs 213 Crores, on March 27, 2023.

    As of 04 Jul, 2025, Bilcare share price is ₹71.5. The stock opened at ₹73.2 and had closed at ₹73.2 the previous day. During today’s trading session, Bilcare share price moved between ₹71.32 and ₹74.39, with an average price for the day of ₹72.85. Over the last 52 weeks, the stock has recorded a low of ₹51.00 and a high of ₹97.99. In terms of performance, Bilcare share price has declined by 11.6% over the past six months and has increased by 24.86% over the last year.

    Read More
    Bilcare SIP Return Calculator

    Over the past

    1 year
    3 years
    5 years

    Total Investment of ₹65,00,000

    Would have become ₹73,82,349 (+13.57%)

    Daily SIP of 25,000 would have become 73,82,349 in 1 year with a gain of 8,82,349 (+13.57%)

    View details of Market Depth

    Bilcare Fundamental

    Market Cap (in crs)

    168.40

    Face Value

    10

    Turnover (in lacs)

    5.08

    Key Metrics

    Qtr Change %
    27.01% Fall from 52W High
    -23.9
    Dividend yield 1yr %
    0

    Bilcare Key Financials

    View more

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    *All values are in ₹ Cr.

    Bilcare Quarterly Revenue
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    194.03 Cr
    198.13 Cr
    201.74 Cr
    194.14 Cr
    200.07 Cr
    Bilcare Yearly Revenue
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    806.5 Cr
    769.7 Cr
    991.84 Cr
    859.28 Cr
    641.11 Cr
    1923.88 Cr
    Bilcare Quarterly Net Profit/Loss
    Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024
    5.04 Cr
    -16.25 Cr
    -29.93 Cr
    -15.02 Cr
    -19.67 Cr
    Bilcare Yearly Net Profit/Loss
    Mar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
    -56.16 Cr
    -58.54 Cr
    50.21 Cr
    -4.36 Cr
    -11.17 Cr
    -99.02 Cr

    Top Mutual Fund Invested in Bilcare

    Promoter
    30%
    Public
    70%
    Promoter
    30%
    Public
    70%
    Promoter
    30%
    Public
    70%
    Promoter
    30%
    Public
    70%
    Promoter
    30%
    Public
    70%
    Promoter
    30%
    Public
    70%

    Bilcare Technical Analysis

    Moving Averages Analysis
    71.5
    Current Price
    Bullish Moving Averages
    1
    Bearish Moving Averages
    15
    5Day EMA
    73.30
    10Day EMA
    74.30
    12Day EMA
    74.70
    20Day EMA
    75.60
    26Day EMA
    76.00
    50Day EMA
    76.40
    100Day EMA
    74.80
    200Day EMA
    71.60
    5Day SMA
    73.60
    10Day SMA
    74.40
    20Day SMA
    76.40
    30Day SMA
    77.30
    50Day SMA
    76.00
    100Day SMA
    74.30
    150Day SMA
    72.30
    200Day SMA
    69.10
    Delivery & Volume

    Delivery & Volume

    PeriodCombined Delivery VolumeNSE+BSE Traded Volume
    Day Rs
    6333 Rs
    7101 Rs
    Week Rs
    7209 Rs
    8925 Rs
    Month Rs
    7171 Rs
    11527 Rs
    72.41
    Pivot
    Resistance
    First Resistance
    73.50
    Second Resistance
    75.48
    Third Resistance
    76.57
    Support
    First Support
    70.43
    Second support
    69.34
    Third Support
    67.36
    Relative Strength Index
    35.14
    Money Flow Index
    14.24
    MACD
    -1.30
    MACD Signal
    -0.80
    Average True Range
    3.53
    Average Directional Index
    17.31
    Rate of Change (21)
    -10.49
    Rate of Change (125)
    -13.96

    Bilcare Latest News

    30 JUN 2025 | Monday

    Bilcare Ltd-$ - 526853 - Closure of Trading Window

    30 MAY 2025 | Friday

    Bilcare Ltd-$ - 526853 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    30 MAY 2025 | Friday

    Bilcare Ltd-$ - 526853 - Compliances-Reg.24(A)-Annual Secretarial Compliance

    View More

    Bilcare Share Price FAQs

    You can easily buy Bilcare shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.

    The 52-week high and low of Bilcare share price is ₹97.99 and ₹51 as of 4/7/2025.

    Please be aware that Bilcare stock prices are subject to continuous fluctuations due to various factors.

    Popular Stocks
    65.53
    +0.26 (+0.40%)
    139.24
    -0.46 (-0.33%)
    689.05
    -1.35 (-0.20%)
    2,599.10
    -12.10 (-0.46%)
    166.67
    -0.85 (-0.51%)
    391.40
    +0.75 (+0.19%)
    163.01
    -2.90 (-1.75%)
    261.40
    +0.55 (+0.21%)
    427.55
    +1.30 (+0.30%)
    401.00
    +1.10 (+0.28%)
    Top Gainers
    925.30
    +15.15 (+1.66%)
    1,640.70
    +22.00 (+1.36%)
    1,307.40
    +16.10 (+1.25%)
    1,442.80
    +16.90 (+1.19%)
    270.05
    +3.00 (+1.12%)
    Top Losers
    5,456.00
    -735.00 (-11.87%)
    163.01
    -2.90 (-1.75%)
    5,629.00
    -87.00 (-1.52%)
    1,655.20
    -16.70 (-1.00%)
    12,646.00
    -106.00 (-0.83%)
    Open Demat Account
    +91 -

    Open Demat Account
    +91 -